Stanley M Marks
Overview
Explore the profile of Stanley M Marks including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barrientos J, Ayed A, Cha A, Du S, Fang B, Hall R, et al.
Target Oncol
. 2023 Sep;
18(5):727-734.
PMID: 37728835
Background: Despite recent approvals of lifesaving treatments for chronic lymphocytic leukemia (CLL), real-world data on the tolerability of the Bruton tyrosine kinase inhibitor ibrutinib for CLL treatment are lacking, especially...
2.
Haidar G, Agha M, Bilderback A, Lukanski A, Linstrum K, Troyan R, et al.
Clin Infect Dis
. 2022 Feb;
75(1):e630-e644.
PMID: 35179197
Background: We studied humoral responses after coronavirus disease 2019 (COVID-19) vaccination across varying causes of immunodeficiency. Methods: Prospective study of fully vaccinated immunocompromised adults (solid organ transplant [SOT], hematologic malignancy,...
3.
Kuang C, Park Y, Augustin R, Lin Y, Hartman D, Seigh L, et al.
Clin Epigenetics
. 2022 Jan;
14(1):3.
PMID: 34991708
Background: DNA mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC) is not responsive to pembrolizumab monotherapy. DNA methyltransferase inhibitors can promote antitumor immune responses. This clinical trial investigated whether concurrent...
4.
Gordan L, Marks S, Xue M, Nagovski N, Lambert J, Smith R
Future Oncol
. 2021 Oct;
18(3):301-309.
PMID: 34709061
The introduction of daratumumab into the treatment of multiple myeloma has improved outcomes in patients; however, community oncologists often dose more frequently than the US FDA-approved label. Integra analyzed its...
5.
Schwartzberg L, Marks S, Gabrail N, Geller R, Kish J
J Comp Eff Res
. 2019 May;
8(9):657-670.
PMID: 31070042
To evaluate real-world effectiveness of guideline-recommended palonosetron-containing antiemetic regimens in patients receiving highly (HEC) or moderately emetogenic (MEC) chemotherapy. This retrospective analysis used records of adults receiving first-line chemotherapy and...
6.
Schwartzberg L, McLaughlin T, Geller R, Gabrail N, Marks S
J Comp Eff Res
. 2018 Oct;
7(12):1161-1170.
PMID: 30304955
Aim: Real-world palonosetron effectiveness was evaluated in an antiemetic regimen with highly emetogenic chemotherapy (HEC). Patients & Methods: In this Phase IV, prospective, multicenter observational study, HEC-treated cancer patients received...
7.
Vargo J, Patel A, Glaser S, Balasubramani G, Farah R, Marks S, et al.
Cancer
. 2017 Apr;
123(16):3176-3185.
PMID: 28380259
Background: Extranodal natural killer T-cell lymphoma, nasal-type (NKTCL), is a rare malignancy in Western populations and is thus challenging for standardization of care and a prospective study. This study was...
8.
Gonzalez N, Puwanant A, Lu A, Marks S, Zivkovic S
Neuromuscul Disord
. 2017 Jan;
27(3):266-268.
PMID: 28109638
Immune checkpoint molecules are potent regulators of immunologic homeostasis that prevent the development of autoimmunity while maintaining self-tolerance. Inhibitors of immune checkpoint molecules are used as immunotherapy in the treatment...
9.
Lim S, Lim M, Raptis A, Hou J, Farah R, Marks S, et al.
Am J Hematol
. 2015 May;
90(8):715-8.
PMID: 26010177
While some patients with high-risk acute myeloid leukemia (AML) require one or two cycles of induction chemotherapy to achieve a complete remission (CR), others require more than two cycles. We...
10.
Sathanoori M, Shekhter-Levin S, Marks S, Swerdlow S
Cancer Genet Cytogenet
. 2007 Jan;
172(2):158-64.
PMID: 17213026
We report the case of a 62-year-old man who presented with splenomegaly, leukocytosis, anemia, and thrombocytopenia. Examination of the peripheral blood, bone marrow, and spleen revealed involvement by mantle cell...